The Biomedical Industry Commercialisation Bridge Grant (CBG) was a competitive Western Australian (WA) Government grant, funded through the $8.65 million Health and Medical Life Sciences Industry Strategy funding.
The CBG has been designed to assist WA biomedical companies in bridging the gap between commercialised innovation and a sustainable, scalable business, creating more jobs, and economic diversification for Western Australia.
In 2025, three local companies will receive up to $200,000 in grant funding through the CBG.
Meet the 2025 recipients:
| Business Name | Grant | Project Title |
| Pretect Devices Pty Ltd | Paving the commercialization pathway for Vedette | $129,900 |
| Navier Medical Ltd | Mosaic: clinical workflow integration, automation, and market entry | $162,500 |
| Rex Ortho Pty Ltd | Next generation expandable orthopaedic screw platform technology | $200,000 |
Print this page
